weather near-term headwind result
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jul
estim jul
price data jul
rate updat jul
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
think gdp-plu busi case plu
testament value-addit natur compani
product churn virtual inimit research
compani commit leverag innov across
dispar busi make worth sum
part commit manifest alloc
net sale expect increas toward
back toward forecast firm earn
gross profit everi dollar spent forecast
rel line recent experi histor
significantli greater highli innov firm
portfolio
posit
faster-grow portion term industri well
geographi think healthcar segment gradual take
pivot role contribut firm revenu
oper incom mix particularli economi
geograph expos matur see segment rise
larger portion firm re-seg revenu end
explicit forecast asid superior profit healthcar
benefit sever secular trend includ age popul
rise chronic diseas surgic procedur well demand
effici manag larg volum medic data
acquisit acel slightli pricey also provid
firm stronger foot advanc wound care market
also expect outsiz growth safeti portfolio driven
need replac age infrastructur increas urban
develop world therefor model near top-lin
compound annual growth rate
also see slowli continu margin expans stori
tandem restructur effort expect effort
involv increas share resourc cut raw materi
cost reduc global headcount posit optim
firm massiv intern manufactur footprint among
initi
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
diversifi industri busi exist sinc
minnesota mine manufactur known
research develop prowess organ four busi
segment safeti industri transport electron healthcar
consum compani revenu come outsid
unit state industri segment constitut firm
net sale mani compani product touch concern
varieti consum industri
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
manag weather near-term headwind
face
quarter sale billion year year
rel flat organ local-curr basi neg
year year underli margin exclud
impact restructur rose basi
point welcom develop given
difficult comp last year second quarter amid boost
custom demand ahead enterpris resourc
plan roll-out compani also maintain guidanc
first time recent memori suggest compani
adapt recent weak automot
semiconductor chines market well effect
custom inventori destock even noth
latest result alter fundament view firm
rais fair valu estim
howev entir due time valu money
made chang model time
sale recogn acel acquisit
expect close fourth quarter
neglig impact fair valu estim fair valu
estim impli forward multipl
adjust ep estim
midpoint manag full year
adjust ep guidanc rang note
push time sale relat acel
manag guidanc never bake acquisit
despit recent organ top-lin growth headwind
still expect organ local currenc growth full
year mid-point manag
guidanc small boost mmodal report
turn firm segment first quarterli
result use firm recent re-segment
reduc portfolio five segment four
result pleas see health care sale grow
includ organ basi posit organ
sale result seen healthcar inform system
medic solut food safeti oral care wed like
continu see strong organ result segment
line mid-single-digit top-lin assumpt
encouragingli manag highlight call
despit overal weak china health care organ top
line rose high-singl digit region
safeti industri top line grew year
year organ result fell base declin industri
adhes tape electr market abras closur
mask well automot aftermarket
still expect continu weak automot
electron market throughout rest year
continu impact top-lin perform
segment manag guidanc also point toward
organ sale declin transport
organ agre analysi project full-
year organ sale declin neg new
segment compani make portfolio move
like includ divestitur ga detect
part scott safeti acquisit think
import compani focu high-valu portion
person safeti market believ leverag
 lab creat differenti product price
premium rest market phenomenon see
throughout rest busi
final compani also provid slight updat pfa
commit sustain practic note
adjust ep retain manag practic
adjust ep estim contempl
impact project pfa oblig firm
may due difficult assess time potenti
settlement even point impact
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
compound annual growth rate model
top-lin assumpt project growth
firm subseg safeti industri
largest segment net sale see growth partiallli
come abras adhes enjoy multipl
applic throughout firm abras growth
driver includ rapid expans intern automot
product along robust growth world-wide
construct industri also believ safeti
industri segment benefit person safeti
product busi high brand loyalti
differenti earn premium expect
global popul increasingli shift live urban
area well improv standard live result
demand build renov project drive
growth health care think signific portion
growth come medic consum particularli
dispos medic suppli driven increas
incid chronic diseas rise surgic
procedur across globe electron part
transport electron see divis benefit
increas adopt smartphon
televis well increas need energi
effici electr compon consum see
continu net sale growth per year averag
base continu innov addit product
see slight uptick margin medium term
driven lower manufactur cost sell gener
administr expens percentag net sale
base increas oper effici off-set slight
increas expens percentag net sale
stage ii model return new invest capit
growth match long-term
expect nomin global growth
project oblig minim fair valu
less per share current concern
dont impact thesi believ
oblig coupl slow organ growth could
somewhat constrain cash surmis would
somewhat limit buyback potenti under-valued share
futur given compani state prefer
increas dividend line earn time
overal share trade discount
underli valu longer see appreci
discount junctur
review second-quart result
slightli rais fair valu estim per share
previous rais due time valu
money fair valu estim impli time
price-to-earnings multipl adjust ep estim
well time enterpris value/ebitda multipl
mere discount second-quart
earn report longer believ share repres
believ increas revenu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
assign low uncertainti rate given high
degre confid narrow rang potenti
intrins valu compani
bull-cas scenario fair valu estim rise
per share top-lin growth
compound-annual-growth-rate oper margin improv basi
point level assumpt
bull case relat increment share gain
oppos faster growth market product
portfolio expos base assumpt
strength firm portfolio respons custom
instanc firm benefit addit exposur
faster grow portion specif healthcar
also afford firm addit oper profit
high-margin segment margin
assumpt credit mani manag initi
deriv region servic center common
enterpris resourc plan platform well addit
lean measur drive oper effici return
research capit rise gross profit
everi dollar spent
bear-cas scenario fair valu estim drop
per share top-lin growth rise
compound-annual-growth-rate near bottom manag
guidanc oper margin compress toward
bottom rang recent histor perform
assumpt bear case relat increment
share loss variou categori product portfolio
base increas competit diminish brand
equiti instanc overal portfolio mix also
less rich higher-grow portion portfolio
specif high-margin healthcar effect
competit manifest oper margin
forc spend acceler pace rel
net sale keep competitor bay bear-cas
scenario also assum mani manag initi
yield addit oper effici bear case
furthermor fail bear fruit final return research
capit fall gross profit everi
dollar spent
believ wide econom moat base
intang asset cost advantag diversifi
industri space think central
leverag core compet key build
endur competit advantag innov
powerhous maxim util platform
across multipl busi segment byproduct
includ patent brand proprietari technolog
firm spend net sale compar
median global innov
median diversifi industri firm mani
firm say innov yield invest
quantifi superior return research capit
outpac name top innov
compani name boston consult group everi
dollar spent yield gross
profit versu averag top case
even everi name list technolog sector
aggreg accord statista technolog
sector account nearli global spend
compar entir industri
sector three-year cycl return research capit
outpac firm top except bcg
number-on rank firm think testament
busi model place premium
effect commerci firm receiv
custom interact per year major
product develop cater specif custom input
oppos third-parti market insight custom
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
relationship difficult-to-repl intang asset
cultiv centuri worth oper
addit benefit effici elimin
program bear littl probabl commerci
altern acceler potenti
high impact high probabl success also
firm senior engin time unbudget
work new idea project independ
strong brand high share mind includ
scotch-brit ace bandag mani brand
command premium price exampl
standard yellow post-it note typic sell price
premium compar gener counterpart
believ consum will pay extra premium
associ product given reput
high qualiti overal firm steadili risen brand
valu recent year climb interbrand top
best global brand ahead
well-known brand like visa
product touch concern nearli everi
industri firm portfolio overli depend
singl product categori increas confid
long-run return invest capit
addit throughout histori firm benefit
global patent award accord
search patent trademark offic
award patent sinc
believ current patent portfolio exce carri
amount million list balanc sheet
account permit write
intang asset belief anchor firm proven
consist abil use asset gener excess
return think major
recent patent portfolio util patent
base data intellectu properti owner
associ qualifi design invent
must novel new non-obvi given compar
higher hurdl obtain util patent offer
advantag design patent given intellectu
properti protect around invent function
also protect mani differ variat product
singl approv file think complex
disrupt technolog reflect strength intang
asset moat sourc case microrepl
technolog use road sign grinder overhead
technolog platform manufactur scale
allow achiev lowest unit cost
categori compet result enjoy
gross margin sale versu
median compar peer firm share resourc
provid economi scope abras
technolog affect industri construct
retail well automot
aftermarket collis repair firm adhes also
use wide rang applic scotch tape
post-it note tegaderm medic dress
emphasi region suppli chain reduc
complex manufactur process allow
shorter suppli chain fewer stock-keep unit
common process ultim translat diminish
demand work capit greater capit effici
drive unit cost improv custom experi
fewer back order cost custom servic
benefit amplifi common enterpris resourc
plan platform
function across suppli chain procur
addit benefit get
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
posit option moat-widen
opportun greater licens intellectu
properti particularli electron energi segment
lack organ revenu growth consist
segment compani past licens
certain ip around electron materi solut
licens deal offer advantag incur
addit cost ip develop thu
evid initi still see intang
moat sourc stabl
cost advantag moat sourc firm expand
gross oper margin recent year said
believ mani improv uniqu
admiss entir industri benefit
includ benefit yield averag lean sigma
project averag lean project yield
benefit
aggreg compani deriv estim billion
save lean project think
testament effect lean sigma
program howev attribut margin benefit
process oper excel oppos firm
uniqu irreplac lean process
believ firm cost advantag moat sourc stabl
geograph proxim custom firm also
deriv economi scale manag suppli chain
across broader geographi vertic integr
firm manufactur mani raw materi lower
cost competitor moreov plant around
world anchor site time
larger typic plant larger plant
averag product smaller plant
tend drive inventori turn averag faster
phenomenon hold true firm distribut
center faster smaller local
calcul period
achiev increment return tangibl asset
least past year return
capit includ goodwil doubl
estim cost capit even year
compani endur neg sale growth even
worst year past year still manag earn
return includ goodwil clear weight
averag cost capit hurdl time
result high degre confid
continu produc excess return least next
view moat trend stabl quantit
five-year forecast adjust return invest capit
modestli line five-year histor adjust
return invest capit net
goodwil intang moat sourc firm
proprietari technolog continu support
consist spend approach
revenu sever year variou five-year cycl
return research capit rel constant
fluctuat gross profit everi
dollar spent difficult confirm believ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
continu emphas innov
spend percentag net sale total nearli
owhil earn return doubl
cost capit year firm effort
struggl gener fresh organ growth
oth firm continu benefit share
technolog platform develop product often
multipl applic
like profit segment geographi
expos faster-grow portion global
allow easili earn goal
time growth industri product index
challeng automot semiconductor
channel custom inventori destock
econom slowdown china
struggl attract retain best
brightest scientist engin natur
gravit toward technolog sector
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
view well capit certainli
materi increas leverag mind
end debt equiti stand time
net debt ebitda stood time high
compar industri peer higher
histor leverag project increas
time end heel greater
leverag acel acquisit overli
concern figur firm interest coverag
stand time ebit interest expens
year-end note one credit rate agenc
downgrad outlook neg reduc
top-lin organ growth outlook
expos sever risk view critic
risk compani would come form complac
pivot away commit innov
see sign risk come fruition although firm
decreas spend slightli percentag sale
think short-term issu relat mostli
time divestitur continu monitor
compani alloc capit still believ
manag remain deepli commit cultur
diminish brand power chang custom
prefer market accept new product
develop pipelin firm abil
find integr bolt-on acquisit supplement
organ revenu growth could affect revenu
assumpt plu minu well slow
growth china particularli given rel high
exposur asia-pacif region rel peer
overal sale firm numer on-
off-balance-sheet environmental/leg risk label
commit conting recent
settl environment suit earlier year home
risk believ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
state minnesota risk contagion
similar suit state think risk rel
immateri long run
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
fidel select envir alt engi port
capit research manag compani
share
fund
share
fund
assign manag exemplari stewardship rate
michael roman becam ceo juli take
well-regard ing thulin
year capac chief oper offic execut
vice presid roman purview firm
intern oper well five busi
segment serv roman head
doubt roman materi pivot playbook
laid roadmap particularli sinc
intim involv strateg plan process
past roman emphas growth
organ invest acquisit continu
leverag insight around critic custom product
development-a strategi like view recent
re-affirmed investor day roman
present specif mention build
success sinc like roman focus
strateg prioriti toward healthcar
safeti industri portion portfolio roman
acquisit think need augment
organ growth provid target price right
one acquisit view posit acquisit scott
safeti roman oversaw integr busi
gain busi combin
lead person safeti portfolio acquisit acel
largest ever optic cheap improv
posit advanc wound care market
opportun addit revenu synergi
deal model
reason behind exemplari stewardship rate
simpl first firm improv free cash flow convers
thulin instal
percent recent year even thulin increas
firm spend percentag net sale
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
summit share best practic
custom sustain final proven
leader field decadeslong pollut
prevent program appreci emphasi
water reduct effort well reduc raw materi
landfil wast
tenur free cash flow eb
overli concern expect bounc back head
next year -- expect convers equal
averag go forward plu minu year
year second import manag
increas firm pay-out ratio begin
tenur left roman
continu pay gener dividend pay-out ratio
earn top end rang
multi-industri peer typic pay
appreci oper steadi
low-growth industri prefer return capit
sharehold overpay acquisit buy back
share
exampl
instanc prefer manag pay
aggress monitor cost go far cancel
firm annual meet product expo interest
sharehold also appreci thulin commit
preserv polici unalloc
assign senior engin well
reluct impos much process cost
innov believ commit remain
steadfast firm roman leadership
less attract price
compani leadership thulin wise emphas
sustain view treat opportun
oppos threat think firm well
posit capit increas paradigm shift
particularli mani solut align well esg
prioriti mani technolog develop
electron energi segment could benefit firm
stakehold trend toward green
solut exampl includ firm filtrat initi
use low-foul membran also note
compani commit sustain health
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
manag weather near-term headwind
face
quarter sale billion year year
rel flat organ local-curr basi neg
year year underli margin exclud
impact restructur rose basi
point welcom develop given
difficult comp last year second quarter amid boost
custom demand ahead enterpris resourc
plan roll-out compani also maintain guidanc
first time recent memori suggest compani
adapt recent weak automot
semiconductor chines market well effect
custom inventori destock even noth
latest result alter fundament view firm
rais fair valu estim
howev entir due time valu money
made chang model time
sale recogn acel acquisit
expect close fourth quarter
neglig impact fair valu estim fair valu
estim impli forward multipl
adjust ep estim
midpoint manag full year
adjust ep guidanc rang note
push time sale relat acel
manag guidanc never bake acquisit
despit recent organ top-lin growth headwind
still expect organ local currenc growth full
year mid-point manag
guidanc small boost mmodal report
turn firm segment first quarterli
result use firm recent re-segment
reduc portfolio five segment four
result pleas see health care sale grow
includ organ basi posit organ
sale result seen healthcar inform system
medic solut food safeti oral care wed like
continu see strong organ result segment
line mid-single-digit top-lin assumpt
encouragingli manag highlight call
despit overal weak china health care organ top
line rose high-singl digit region
safeti industri top line grew year
year organ result fell base declin industri
adhes tape electr market abras closur
mask well automot aftermarket
still expect continu weak automot
electron market throughout rest year
continu impact top-lin perform
segment manag guidanc also point toward
organ sale declin transport
organ agre analysi project full-
year organ sale declin neg new
segment compani make portfolio move
like includ divestitur ga detect
part scott safeti acquisit think
import compani focu high-valu portion
person safeti market believ leverag
 lab creat differenti product price
premium rest market phenomenon see
throughout rest busi
final compani also provid slight updat pfa
commit sustain practic note
adjust ep retain manag practic
adjust ep estim contempl
impact project pfa oblig firm
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
may due difficult assess time potenti
settlement even point impact
project oblig minim fair valu
less per share current concern
dont impact thesi believ
oblig coupl slow organ growth could
somewhat constrain cash surmis would
somewhat limit buyback potenti under-valued share
futur given compani state prefer
increas dividend line earn time
overal share trade discount
underli valu longer see appreci
discount junctur
slightli lower fve evalu
take closer look pfa exposur slightli
lower fair valu estim firm
reserv pfa liabil current total million
took first quarter importantli howev
reserv sole manufactur liabil face
directli facil specif three site
unit state two europ reserv
includ product liabil exposur estim
much greater reserv
view exposur product side
billion base scenario effect brought
fair valu estim off-set boost
time valu money bull case number fall
billion bear case rise billion also
amort oblig cours explicit
forecast less final year would calcul valu
perpetu adjust oblig part
adjust ep assumpt bottom line believ
lot reaction stock price base irrat
fear oblig could total ten billion dollar
dont agre base avail evid
calcul exposur base inform
latest file first-quart includ number
jurisdict litig pend well
estim total respons base
minnesota settlement pfa famili
manmad fluorin organ chemic use
sinc stain-repel scotchgard
firm also sold pfa compani make teflon
firefight foam among applic
strong molecular bond found water suppli
understand dont break natur
phase compound
assum highest
concentr exposur howev home
state minnesota settl state
attorney gener million public polici
perspect also dont believ extent
settlement mirror minnesota found
state stock price trade price
think share would offer attract
risk/reward wide-moat enterpris provid long-term
investor could stomach short-term volatil hedg
largest deal advanc wound
may wide-moat rate announc far largest
deal ever advanc wound care provid acel
review deal
impact re-
segment incorpor first-quart result
guidanc lower fair valu estim per share
previous primari driver lower
valuat manag recent outlook organ
growth throughout rest year markedli
fell near-term expect nevertheless
intrins valuat perspect remind investor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
saw previous stock overvalu
ralli prior first-quart earn believ
long-term thesi stock remain intact
continu retain wide-moat stabl trend exemplari
stewardship low uncertainti rate stock price
think stock trade within realm
reason term price fair valu ratio
net synergi deal seem expens side
us time unadjust ebitda model deal
slightli valu dilut akin market reaction today
saw stock drop throughout trade
day believ deal rational highli depend
manag abil extract ambiti cost synergi
target revenu cours three
year sever concern daunt task
first manag acknowledg slow react
market headwind prompt lower guidanc
short-cycl busi inher hard predict
earli clue slowdown trickl
china well automot electron rest
coverag second manag undergo
restructur program recent announc
also juggl sever lawsuit relat pfa
asbesto litig relat respir
overli concern develop
yet think theyr greater initi appreci
continu monitor third acel
set ipo coupl week ago suggest
will pay even higher multipl top
econom cycl -- gener formula creat long-
term sharehold valu fourth billion enterpris
valu includ agre assum roughli billion
debt doubl previou larg deal
billion capit safeti fifth organ growth
slow compani dump use new
vital index base logic fruit
spend would show organ top-lin result
pull back slightli spend rel
silver bullet figur chanc theyv spent
less also unfortun side effect earn
less metric use track return research
capit gross profit prior-year spend last year
metric dip compar last year
medium-term expect
nevertheless think issu short term
normal ebb flow still see moat around
busi intact compar lower price target
estim see consensu
firm intang asset moat doesnt offer greater
inflat annual price increas gener price
consum product competitor last
year abl off-set inflat price without
sacrif volum still maintain premium
sixth recent credit outlook downgrad
neg one three rate agenc
debt doesnt overli concern us higher level
weve seen histor amid headwind final
weve thought histor prefer organ
growth large-scal regular part
firm dna acel moreov doesnt appear
grow materi faster long-term
segment expect organ acel
posit side ledger howev like
compani focus acquir target fit
firm strateg rational doesnt appear take
far outsid core compent acel
portfolio seem complement offer health
segment tandem safeti portfolio remain
larg part long-term thesi stock expect
strong secular trend acel exposur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
 market babi boomer popul age
expect benefit rise incid
chronic diseas like diabet well surgic
procedur word glad fish
right pond could wrong acknowledg
manag could extract valu see
slightli rich deal prefer sit sidelin
mike roman first challeng helm apr
wide-moat first-quart earn noth short
swing miss weve longtim fan
compani uniqu corpor cultur even think
declin stock market price april
larg forese least junctur futur
indic rate april
announc around time last year fair valu
estim repres lowest price target consensu
estim built bottom-up analysi busi
subseg simpli couldnt understand
constitu busi would support stock price
april close particularli amid markedli slow top-
line organ growth end market signific
amount exposur slow automot
electron end market well china compar
peer entir asia-pacif region repres nearli one
third sale
roman stewardship moreov compani
walk back guidanc sever occas five
count that one year time
understand short-cycl busi inher hard
predict lack massiv backlog long-cycl
busi honeywel count
busi exampl think prudenc could
spare irrat rise stock price april
announc howev expect modestli
reduc fair valu estim despit view
continu near-term headwind still
retain wide moat low uncertainti stabl trend
quarter total sale billion
year year reduct neg organ
fell basi point year year
adjust signific litig charg flow
biggest sore spot automot
similarli vex rockwel autom earlier oem
channel year year driven first quarter
global car
contribut automot oem channel well
electric-rel busi year year
manag also report china hong kong saw
top line year year tough comp
last year saw sale rise year year
result pressur previous announc
re-segment earlier quarter see
segment reduc four five segment
includ health safeti industri transport
electron consum contemporan
april announc compani announc
undergo restructur wit broad-bas
reduct job global restructur
mean take million charg
accord manag expect see annual
save million million million
year alon think restructur signal two
thing go forward continu struggl
grow materi faster global organ basi
given sheer size restructur repres mike
roman first real test ceo
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
even think wide moat around busi
thesi remain intact assur ceo mike
roman comment call said
invest would say innov broadli
fundament promis investor
firm preserv intang asset base premium
price product rel competitor
give take think imper continu
spend sale research develop
high return capit afford opportun
miss
exampl one area near-term poor perform
concern drug deliveri health
segment remain fundament part thesi
consum busi still see high growth
given rise surgic procedur chronic ill
like diabet particularli babi boomer popul
age drug deliveri specif project-bas busi
line work solut may target rise
pulmonari diseas around world lumpi busi
growth consist wed rather invest
money within moat protect despit year-over-year
one area keep long-term eye howev
effect litig relat pfa respir
pop increasingli radar speak
media sourc review firm file
firm promis addit disclosur main
concern pfa litig particularli repres
common fact pattern million settlement
paid minnesota last year risk contagion
form far lawsuit spread state
reserv judgment test adequaci
reserv review sourc
minimum anticip slog given resolut
depend state-by-st approach
thesi wide-moat rate remain intact
firm continu perform expect jan
wide-moat rate decent fourth quarter
broadli line fourth-quart full-year
expect roll model forward anticip
modestli rais fair valu estim base
mostli time valu money new pension
assumpt leav long-run expect
rel intact may make addit minor
chang firm releas annual report
sub-seg inform even retain
wide-moat low uncertainti stabl trend exemplari
report full-year sale billion versu
expect billion growth year
year organ local-curr basi ep
also modestli line expect
full year compar estim adjust
net tax expens cent per share after-tax
expens relat first-quart legal settlement
adjust ep year came current
gaap ep expect prior announc result
come compar manag current
guidanc midpoint
manag expect larg proport
improv full-year result come
organ sale growth portfolio manag base
manag commentari call expect
major organ sale growth back-end load
particularli given tougher first-half comp
note free cash flow convers dip year
rel prior four year compar
rang overli concern
expect improv hover around next
year remain one highest qualiti diversifi
industri coverag term free cash flow
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
continu monitor slow growth china particularli
given geograph exposur asia-pacif region
typic revenu given year return
research capit current year gross profit divid prior
year spend dip slightli year compar
prior-year result line
expect year importantli
long-term expect continu believ
high-qual well-run compani believ
market adequ apprais futur earn potenti
convers free cash flow divid net incom
turn segment coupl item stood
us health return strong perform quarter
organ sale year year quarter
sale health grew multipl sub-seg
solut even oral care laggard
earlier part year drug deliveri continu
declin expect growth volatil given
project-bas natur busi expect
continu see growth flow
acquisit modal technolog busi safeti
graphic tradit strong perform saw
organ growth year year quarter one
item found interest acquisit
scott safeti perform well growth double-
digit base manag dialogu analyst tyco
never abl achiev type growth unit
ceo mike roman tout win combin
two team specif term person safeti
portfolio well project theyv pick
recent nice tailwind electron energi
nice quarter sale particularli strong
survey firm result manag
commentari believ thesi remain intact weve
consist believ growth
portfolio driven safeti
graphic given long-term secular trend drive
urban develop world need updat
age infrastructur grow awar worker-
relat safeti relat regul age popul
risk increas chronic ill like diabet
asthma surgic procedur well need
manag larg amount health data one item well
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
